Prostate cancer represents one of the most common forms of cancer in men, with approximately 1 in 8 men diagnosed during their lifetime. According to statistics from the National Cancer Institute, in 2020, more than 58,000 new cases were recorded in France. This alarming figure highlights the crucial importance of early detection, which can play a decisive role in patient survival.
Early detection helps identify cancer at a stage where it is still localized, providing better treatment options and a higher survival rate. According to a study conducted by the World Health Organization, the five-year survival rate for prostate cancer detected early can reach 99%. On the other hand, for advanced cases, this rate drops dramatically to around 30%.
Current recommendations recommend that men from the age of 50, or from the age of 45 for those with a family history, carry out regular screening. This screening is generally done by testing the PSA (prostate specific antigen) in the blood, possibly followed by a biopsy to confirm the diagnosis.
Despite these recommendations, many men are still hesitant to get tested, often due to fear of the results or discomfort of the procedures. It is essential to raise public awareness of the importance of this screening. Indeed, an awareness campaign carried out in 2021 showed that men informed of the risks and benefits of screening were 40% more likely to take the test.
Prostate cancer should not be taboo. By encouraging early detection, we can save lives. Doctors and health associations should continue to promote the importance of regular checkups and reassure patients about the procedures. Together, we can effectively fight this disease, enabling thousands of men to live longer, healthier lives.
Swiss
